| Financial Year |
March 31 2023 |
| Monetary Funds |
154,268,563.36 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
116,223.00 |
| Accounts Receivable |
209,838,846.24 |
| Advances to Suppliers |
12,154,362.76 |
| Other Receivables |
1,231,968.03 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
138,544,990.53 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,233,187.33 |
| Total Current Assets |
530,755,567.90 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,000,000.00 |
| Investment Properties |
125,198,341.79 |
| Fixed Assetes |
281,305,461.52 |
| Under-construction Projects |
23,514,614.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
241,591,107.22 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
25,312,941.27 |
| Deferred Income Tax Assets |
13,760,644.67 |
| Other Non-Current Assets |
9,505,310.58 |
| Sub-Total of Non-Current Assets |
730,068,346.23 |
| Total Assets |
1,260,823,914.13 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
22,540,792.28 |
| Accounts Payable |
54,586,984.29 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,937,262.71 |
| Taxes Payable |
3,572,798.25 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,312,786.36 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,344,717.15 |
| Other Current Liabilities |
5,218,155.55 |
| Sub-Total of Current Liabilities |
125,095,445.90 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
4,429,200.00 |
| Sub-Total of Non-Current Liabilities |
9,618,980.26 |
| Total Liabilities |
134,714,426.16 |
| Paid-In Capital(Or Share Stock) |
128,000,598.00 |
| Capital Surplus |
766,717,080.22 |
| Surplus Reserve |
26,971,214.09 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
165,125,278.78 |
| Minority Stockholder's Interest |
39,295,316.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,086,814,171.09 |
| Owner's Equity（Stockholder's Equity） |
1,126,109,487.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,260,823,914.13 |
